Fundraising Fox
🦊/People
Sign in

Rami Hannoush

Investor

Venture Partner at Versant Ventures

San Diego and San Francisco Bay Area

Find your path to Rami

573 people in our graph share verified history with Rami — schools, employers, funds. One of them is your warm intro.

Anthony PhilippakisunlockedRami: together at Harvard Medical School (2002–2006)
Rami: together at Harvard Medical School
×9Rami: together at Harvard University
Rami: together at Kallyope

About

Venture partner focused on company creation, bringing both investment and drug discovery expertise. Previously a general partner at Mubadala Capital building its U.S. healthcare platform, co-founder and CEO of EpiBiologics, and a 16+ year Genentech R&D leader in oncology and immunology. Holds a Ph.D. in Chemistry from McGill with postdoctoral training at Harvard.

Experience

  1. Versant VenturesVersant Venturescurrent2023 — presentSan Francisco, California, & Toronto, Ontario
  2. Dayra Therapeutics, IncChief Executive Officer and co-foundercurrent2024 — present
  3. Frontier Discovery, IncPresident and CEOcurrent2024 — present
  4. Light Horse TherapeuticsBoard member and co-founding investorcurrent2022 — present
  5. Stablix, Inc.Board Membercurrent2023 — present
  6. Stanford University School of MedicineAdjunct Professor, Department of Chemical and Systems Biologycurrent2014 — present
  7. Stanford University School of MedicineAdvisor, SPARK Programcurrent2016 — present
  8. Cell Chemical Biology by Cell PressAdvisory Board Membercurrent2014 — present
  9. EpiBiologicsChief Executive Officer and co-Founder2021 — 2023San Francisco Bay Area
  10. EpiBiologicsChairman of the Board of Directors2022 — 2023
  11. EpiBiologicsChief Scientific Officer & coFounder2021 — 2023
  12. Auron TherapeuticsBoard Observer2022 — 2023
  13. Juvena TherapeuticsMember Board Of Directors2022 — 2023
  14. Dewpoint TherapeuticsBoard Observer and Scientific Advisory Board Member2022 — 2023
  15. KallyopeInvestor2022 — 2023
  16. NeumoraInvestor2021 — 2023
  17. Mubadala CapitalGeneral Partner | US Ventures2021 — 2023San Francisco, California, United States
  18. GenentechScientific Advisor2021 — 2022
  19. GenentechSenior Group Leader and Senior Principal Scientist2017 — 2021
  20. GenentechGroup Leader / Principal Scientist / Senior Scientist / Scientist2006 — 2017
  21. Harvard UniversityCIHR & NSERC Research Fellow2003 — 2006
  22. McGill UniversityGraduate Research Assistant1998 — 2002

Skills & more

InvestmentsVenture CapitalVenture FinancingEarly Stage VenturesBiochemistry25Cell Biology16Chemical Biology2Molecular Biology13Enzyme Kinetics4Protein Engineering6Cancer BiologyCell Signaling4
+8 moreProtein-protein InteractionsDrug DiscoveryCell CultureProtein ChemistryProtein AssaysAssay DevelopmentBinding AssaysCellular Assays

From Rami's professional profile.

Colleagues at Versant Ventures

Alex Mayweg
Managing Director at Versant Ventures
Alicia Levey
Venture Partner at Versant Ventures
Andrew Jefferson
Operating Partner at Versant Ventures
Ariel Kantor
Principal at Versant Ventures
Barbara Lubash
Managing Director at Versant Ventures
Beckie Robertson
Venture Advisor at Intuitive Ventures
Brad Bolzon
Chairman, Managing Director at Versant Ventures
Brian Atwood
Managing Director at Versant Ventures

Frequently asked questions

Who is Rami Hannoush?
Venture partner focused on company creation, bringing both investment and drug discovery expertise. Previously a general partner at Mubadala Capital building its U.S. healthcare platform, co-founder and CEO of EpiBiologics, and a 16+ year Genentech R&D leader in oncology and immunology. Holds a Ph.D. in Chemistry from McGill with postdoctoral training at Harvard.
Where does Rami Hannoush work?
Rami Hannoush is Venture Partner at Versant Ventures.
Where did Rami Hannoush go to school?
Rami Hannoush studied at Harvard University (Executive Leadership Program, Strategic Management); Harvard Medical School (CIHR and NSERC Postdoctoral Fellow, Chemical Biology); McGill University (Doctor of Philosophy - PhD, Chemistry (with Distinction)).

Founder mafias

Same school

Shared employers